[{"AccountsPayableCurrent_0_Q3_USD":8102000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_1_Q3_shares":1533090.0,"IncrementalCommonSharesAttributableToContingentlyIssuableShares_1_Q3_shares":7588.0,"IncrementalCommonSharesAttributableToShareBasedPaymentArrangements_1_Q3_shares":2538926.0,"AvailableForSaleSecuritiesNoncurrent_0_Q3_USD":2700000.0,"OtherLiabilitiesNoncurrent_0_Q3_USD":8178000.0,"IncomeLossFromContinuingOperationsPerDilutedShare_3_Q3_USD":-1.37,"IncomeLossFromContinuingOperationsPerDilutedShare_1_Q3_USD":0.03,"IncomeLossFromContinuingOperationsPerBasicShare_3_Q3_USD":-1.37,"IncomeLossFromContinuingOperationsPerBasicShare_1_Q3_USD":0.03,"EmployeeRelatedLiabilitiesCurrent_0_Q3_USD":6247000.0,"AllocatedShareBasedCompensationExpense_3_Q3_USD":13934000.0,"AllocatedShareBasedCompensationExpense_1_Q3_USD":6002000.0,"OtherLiabilitiesCurrent_0_Q3_USD":3422000.0,"IncreaseDecreaseInContractWithCustomerLiability_3_Q3_USD":187890000.0,"IncreaseDecreaseInContractWithCustomerAsset_3_Q3_USD":2447000.0,"ContractWithCustomerAssetNetCurrent_0_Q3_USD":2579000.0,"PaymentsToAcquireInvestments_3_Q3_USD":568903000.0,"AvailableForSaleSecuritiesDebtSecuritiesNoncurrent_0_Q3_USD":2700000.0,"IncreaseDecreaseInOtherCurrentLiabilities_3_Q3_USD":1869000.0,"IncomeLossFromEquityMethodInvestments_3_Q3_USD":-613000.0,"AvailableForSaleSecuritiesAmortizedCost_0_Q3_USD":785051000.0,"AvailableForSaleSecurities_0_Q3_USD":785132000.0,"EarningsPerShareDiluted_3_Q3_USD":-1.37,"EarningsPerShareDiluted_1_Q3_USD":0.03,"AvailableForSaleSecuritiesCurrent_0_Q3_USD":560583000.0,"DeferredRentCreditNoncurrent_0_Q3_USD":4311000.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_3_Q3_USD":17000.0,"WeightedAverageNumberOfSharesCommonStockSubjectToRepurchaseOrCancellation_3_Q3_shares":1599760.0,"OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent_1_Q3_USD":-63000.0,"AccretionAmortizationOfDiscountsAndPremiumsInvestments_3_Q3_USD":333000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax_0_Q3_USD":87000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_3_Q3_USD":68030000.0,"RevenueFromContractWithCustomerExcludingAssessedTax_1_Q3_USD":64530000.0,"RestrictedCashNoncurrent_0_Q3_USD":203000.0,"ReclassificationFromAccumulatedOtherComprehensiveIncomeCurrentPeriodNetOfTax_3_Q3_USD":0.0,"ProceedsFromSaleOfShortTermInvestments_3_Q3_USD":1003000.0,"ProceedsFromSaleMaturityAndCollectionsOfInvestments_3_Q3_USD":135300000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_3_Q3_USD":3271000.0,"InterestReceivableCurrent_0_Q3_USD":372000.0,"IncreaseDecreaseInOtherNoncurrentLiabilities_3_Q3_USD":7973000.0,"IncreaseDecreaseInOtherNoncurrentAssets_3_Q3_USD":1373000.0,"GainLossOnSaleOfEquityInvestments_3_Q3_USD":613000.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersOutOfLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetTransfersIntoLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersOutOfLevel3_3_Q3_USD":0.0,"FairValueMeasurementWithUnobservableInputsReconciliationLiabilityTransfersIntoLevel3_3_Q3_USD":0.0,"FairValueLiabilitiesLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueLiabilitiesLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"FairValueAssetsLevel2ToLevel1TransfersAmount_0_Q3_USD":0.0,"FairValueAssetsLevel1ToLevel2TransfersAmount_0_Q3_USD":0.0,"DeferredRevenueRevenueRecognized1_3_Q3_USD":5250000.0,"DeferredRevenueRevenueRecognized1_1_Q3_USD":1750000.0,"ContractWithCustomerLiabilityNoncurrent_0_Q3_USD":91298000.0,"ContractWithCustomerLiabilityCurrent_0_Q3_USD":115614000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_3_Q3_USD":163912000.0,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q3_USD":222052000.0,"CashAndCashEquivalentsFairValueDisclosure_0_Q3_USD":221849000.0,"AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax_0_Q3_USD":6000.0,"AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue_1_Q3_USD":6002000.0,"OtherComprehensiveIncomeLossNetOfTax_1_Q3_USD":-63000.0,"ComprehensiveIncomeNetOfTax_3_Q3_USD":-70988000.0,"ComprehensiveIncomeNetOfTax_1_Q3_USD":1759000.0,"PropertyPlantAndEquipmentNet_0_Q3_USD":8728000.0,"ProfitLoss_3_Q3_USD":-71005000.0,"ProceedsFromIssuanceOfCommonStock_3_Q3_USD":433776000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q3_USD":11816000.0,"PaymentsToAcquirePropertyPlantAndEquipment_3_Q3_USD":1536000.0,"NetIncomeLoss_3_Q3_USD":-71005000.0,"NetIncomeLoss_1_Q3_USD":1822000.0,"NetCashProvidedByUsedInOperatingActivities_3_Q3_USD":161050000.0,"NetCashProvidedByUsedInInvestingActivities_3_Q3_USD":-434136000.0,"NetCashProvidedByUsedInFinancingActivities_3_Q3_USD":436998000.0,"LiabilitiesCurrent_0_Q3_USD":162871000.0,"LiabilitiesAndStockholdersEquity_0_Q3_USD":811075000.0,"Liabilities_0_Q3_USD":266658000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_3_Q3_USD":7885000.0,"IncreaseDecreaseInAccountsPayable_3_Q3_USD":3165000.0,"GeneralAndAdministrativeExpense_3_Q3_USD":29617000.0,"GeneralAndAdministrativeExpense_1_Q3_USD":11177000.0,"CommonStockValue_0_Q3_USD":6000.0,"CommonStockSharesOutstanding_0_Q3_shares":64924073.0,"CommonStockSharesIssued_0_Q3_shares":64924073.0,"CashAndCashEquivalentsAtCarryingValue_0_Q3_USD":221849000.0,"AssetsCurrent_0_Q3_USD":797199000.0,"Assets_0_Q3_USD":811075000.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_3_Q3_shares":10073646.0,"AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount_1_Q3_shares":3442953.0,"AdditionalPaidInCapital_0_Q3_USD":820661000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q3_USD":81000.0,"RetainedEarningsAccumulatedDeficit_0_Q3_USD":-276331000.0,"StockholdersEquity_0_Q3_USD":544417000.0,"AccruedLiabilitiesCurrent_0_Q3_USD":7496000.0,"CommonStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OtherAccruedLiabilitiesCurrent_0_Q3_USD":617000.0,"IncreaseDecreaseInAccruedLiabilities_3_Q3_USD":2485000.0,"WeightedAverageNumberOfSharesOutstandingBasic_3_Q3_shares":51852247.0,"WeightedAverageNumberOfSharesOutstandingBasic_1_Q3_shares":62599193.0,"OtherAssetsNoncurrent_0_Q3_USD":2245000.0,"NonoperatingIncomeExpense_3_Q3_USD":1218000.0,"NonoperatingIncomeExpense_1_Q3_USD":270000.0,"EarningsPerShareBasic_3_Q3_USD":-1.37,"EarningsPerShareBasic_1_Q3_USD":0.03,"CapitalExpendituresIncurredButNotYetPaid_3_Q3_USD":245000.0,"AccruedProfessionalFeesCurrent_0_Q3_USD":632000.0,"WeightedAverageNumberOfDilutedSharesOutstanding_3_Q3_shares":51852247.0,"WeightedAverageNumberOfDilutedSharesOutstanding_1_Q3_shares":65145707.0,"WeightedAverageNumberOfSharesIssuedBasic_1_Q3_shares":64132283.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q3_USD":270000.0,"ResearchAndDevelopmentExpense_3_Q3_USD":110636000.0,"ResearchAndDevelopmentExpense_1_Q3_USD":51801000.0,"PreferredStockValue_0_Q3_USD":0.0,"PreferredStockSharesOutstanding_0_Q3_shares":0.0,"PreferredStockSharesIssued_0_Q3_shares":0.0,"PreferredStockSharesAuthorized_0_Q3_shares":10000000.0,"PreferredStockParOrStatedValuePerShare_0_Q3_USD":0.0001,"OperatingIncomeLoss_3_Q3_USD":-72223000.0,"OperatingIncomeLoss_1_Q3_USD":1552000.0,"OperatingExpenses_3_Q3_USD":140253000.0,"OperatingExpenses_1_Q3_USD":62978000.0,"DepreciationAndAmortization_3_Q3_USD":2371000.0,"CommonStockSharesAuthorized_0_Q3_shares":400000000.0,"ShareBasedCompensation_3_Q3_USD":13934000.0,"WeightedAverageNumberOfSharesIssuedBasic_3_Q3_shares":53452007.0,"Ticker":"RCUS","CIK":"1724521","name":"ARCUS BIOSCIENCES, INC.","OfficialName":"Arcus Biosciences Inc. Common Stock","form":"10-Q","period":"20200930","fy":"2020.0","fp":"Q3","qtrs":"0","uom":"USD","footnote":"nan","Market Cap":"2226368293.0","Country":"nan","Sector":"Health Care","Industry":"Biotechnology: Pharmaceutical Preparations","Market":"NYSE","SP500":"nan","filed":"20201105"}]